MIMOSA's momentum over the past 5 years has been undeniable - but we're not finished yet!
Our MISSION Is to drive equity in Healthcare via our devices and technology.
Introducing the group of leaders sitting at the helm of MIMOSA Diagnostics
Dr. Cross is a Plastic Surgeon with over 20 year’s experience in the skin & wound healing space. She has a PhD in wound healing & is an International Expert in this space.
Dr. Leung has a PhD in Medical Biophysics, from University of Toronto. Previously an assistant Professor in the Department of Medical Imaging at the U of T. He has over 20 years experience in building medical devices.
Over 15 years of experience as a CPA, finance and in Business Development.
Over 30 years of experience in Leadership positions as the President & CEO.
Paul is an elite Life Sciences entrepreneur in the medical technology space. He has raised $25 plus million in equity and dilutive funding and led 3 successful liquidation events, creating over $300M in value for investors.
Head of Regulatory Health Policy at Google Health. Dr. Fang spent 10 years at the FDA in Class II/Class III submissions and audits. He has been advising MIMOSA around its regulatory strategy.
“The MIMOSA Pro offers real-time validation, enabling me to gauge the positive impact of our treatment modalities. This insight empowers me to adapt patient care plans proactively, ultimately leading to improved patient outcomes.”
"Having a portable device that could assess tissue compromise and healing potential would be a game changer."
"MIMOSA will revolutionize how Podiatrists/Chiropodists manage patients. It will be a great tool in the fight to prevent diabetic foot and vascular complications!"
"Multispectral and hyperspectral imaging devices are like the modern day TRICORDERS."